BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 16793844)

  • 1. Patterns of cardiovascular risk in rheumatoid arthritis.
    Solomon DH; Goodson NJ; Katz JN; Weinblatt ME; Avorn J; Setoguchi S; Canning C; Schneeweiss S
    Ann Rheum Dis; 2006 Dec; 65(12):1608-12. PubMed ID: 16793844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
    Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
    Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.
    Roumie CL; Choma NN; Kaltenbach L; Mitchel EF; Arbogast PG; Griffin MR
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1053-63. PubMed ID: 19637402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.
    Wållberg-Jonsson S; Johansson H; Ohman ML; Rantapää-Dahlqvist S
    J Rheumatol; 1999 Dec; 26(12):2562-71. PubMed ID: 10606363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.
    Jacobsson LT; Turesson C; Gülfe A; Kapetanovic MC; Petersson IF; Saxne T; Geborek P
    J Rheumatol; 2005 Jul; 32(7):1213-8. PubMed ID: 15996054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study.
    Peters MJ; van Halm VP; Voskuyl AE; Smulders YM; Boers M; Lems WF; Visser M; Stehouwer CD; Dekker JM; Nijpels G; Heine R; Dijkmans BA; Nurmohamed MT
    Arthritis Rheum; 2009 Nov; 61(11):1571-9. PubMed ID: 19877093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis.
    Van Doornum S; Brand C; King B; Sundararajan V
    Arthritis Rheum; 2006 Jul; 54(7):2061-8. PubMed ID: 16802340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation.
    van Halm VP; Peters MJ; Voskuyl AE; Boers M; Lems WF; Visser M; Stehouwer CD; Spijkerman AM; Dekker JM; Nijpels G; Heine RJ; Bouter LM; Smulders YM; Dijkmans BA; Nurmohamed MT
    Ann Rheum Dis; 2009 Sep; 68(9):1395-400. PubMed ID: 18697775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis.
    Krishnan E; Lingala VB; Singh G
    Circulation; 2004 Sep; 110(13):1774-9. PubMed ID: 15381644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima Indians.
    Jacobsson LT; Turesson C; Hanson RL; Pillemer S; Sievers ML; Pettitt DJ; Bennett PH; Knowler WC
    Arthritis Rheum; 2001 May; 44(5):1170-6. PubMed ID: 11352251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.
    van Halm VP; Nurmohamed MT; Twisk JW; Dijkmans BA; Voskuyl AE
    Arthritis Res Ther; 2006; 8(5):R151. PubMed ID: 16984661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
    Gonzalez A; Maradit Kremers H; Crowson CS; Ballman KV; Roger VL; Jacobsen SJ; O'Fallon WM; Gabriel SE
    Ann Rheum Dis; 2008 Jan; 67(1):64-9. PubMed ID: 17517756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
    Maradit-Kremers H; Crowson CS; Nicola PJ; Ballman KV; Roger VL; Jacobsen SJ; Gabriel SE
    Arthritis Rheum; 2005 Feb; 52(2):402-11. PubMed ID: 15693010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study.
    Achterberg S; Cramer MJ; Kappelle LJ; de Borst GJ; Visseren FL; van der Graaf Y; Algra A;
    Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):424-30. PubMed ID: 20555265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk among adults with chronic kidney disease, with or without prior myocardial infarction.
    Wattanakit K; Coresh J; Muntner P; Marsh J; Folsom AR
    J Am Coll Cardiol; 2006 Sep; 48(6):1183-9. PubMed ID: 16979003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
    Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
    Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden.
    Wallberg-Jonsson S; Ohman ML; Dahlqvist SR
    J Rheumatol; 1997 Mar; 24(3):445-51. PubMed ID: 9058647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting beta2-agonists.
    Appleton SL; Ruffin RE; Wilson DH; Taylor AW; Adams RJ;
    J Allergy Clin Immunol; 2009 Jan; 123(1):124-130.e1. PubMed ID: 19130933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge of cardiovascular risk factors and awareness of non-pharmacological approach for risk prevention in young survivors of acute myocardial infarction. The cardiovascular risk prevention project "Help Your Heart Stay Young".
    Migliaresi P; Celentano A; Palmieri V; Pezzullo S; Martino S; Bonito M; Guillaro B; Brancati C; Di Minno G
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):468-72. PubMed ID: 17379491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.